Van der Ploeg Leonardus H.T. 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Jan 18, 2019
Insider Transaction Report
Form 4
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Transactions
- Sale
Common Stock
[F1]2019-01-16$30.00/sh−200$6,000→ 42,339 total
Footnotes (1)
- [F1]On January 16, 2019, Mr. Van der Ploeg sold 200 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Signature
/s/ Hunter S. Smith, attorney-in-fact for Leonardus H.T. Van der Ploeg|2019-01-18